Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makoto Inoue

Showing results (631-640 of 654) with videos related to

Pageof 66
Sort By:
Cell Stem Cell|December 26, 2017
Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial InfarctionKazutaka Miyamoto, Mizuha Akiyama, Fumiya Tamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiationRyan D Michalek, Valerie A Gerriets, Amanda G Nichols, et al.
Structure (London, England : 1993)|September 3, 2004
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgammaKohei Saito, Takanori Kigawa, Seizo Koshiba, et al.
Journal of Cellular Physiology|July 27, 2007
CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vectorZoltán Rakonczay, Péter Hegyi, Mamoru Hasegawa, et al.
Biomaterials|December 25, 2007
In vivo imaging of gene transfer to the respiratory tractUta Griesenbach, Cuixiang Meng, Raymond Farley, et al.
Gene Therapy|July 20, 2018
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteinsMichael C Paul-Smith, Kamila M Pytel, Jean-François Gelinas, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2012
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapyUta Griesenbach, Makoto Inoue, Cuixiang Meng, et al.
Human Vaccines|April 22, 2011
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectorsHiroto Hara, Hiroto Hara, Takashi Hironaka, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Pageof 66

Showing results (631-640 of 654) with videos related to

Sort By:
Pageof 66
Cell Stem Cell|December 26, 2017
Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial InfarctionKazutaka Miyamoto, Mizuha Akiyama, Fumiya Tamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2011
Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiationRyan D Michalek, Valerie A Gerriets, Amanda G Nichols, et al.
Structure (London, England : 1993)|September 3, 2004
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgammaKohei Saito, Takanori Kigawa, Seizo Koshiba, et al.
Journal of Cellular Physiology|July 27, 2007
CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a Sendai virus vectorZoltán Rakonczay, Péter Hegyi, Mamoru Hasegawa, et al.
Biomaterials|December 25, 2007
In vivo imaging of gene transfer to the respiratory tractUta Griesenbach, Cuixiang Meng, Raymond Farley, et al.
Gene Therapy|July 20, 2018
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteinsMichael C Paul-Smith, Kamila M Pytel, Jean-François Gelinas, et al.
American Journal of Respiratory and Critical Care Medicine|September 8, 2012
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapyUta Griesenbach, Makoto Inoue, Cuixiang Meng, et al.
Human Vaccines|April 22, 2011
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectorsHiroto Hara, Hiroto Hara, Takashi Hironaka, et al.
Modern Rheumatology|September 8, 2015
Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52Yoshioki Yamasaki, Minoru Satoh, Machiko Mizushima, et al.
Plos One|July 2, 2026
Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trialNoriko Yoshida, Yuko Kobayakawa, Kouta Funakoshi, et al.
Pageof 66